Birdwatch Archive

Birdwatch Note

2023-03-07 00:47:26 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Pfizer and BioNTech entered into an agreement for the co-development and distribution of a potential mRNA-based coronavirus vaccine aimed at preventing COVID-19 infection. Data from the clinical trial showed BNT162b2 was 95% effective in preventing Covid-19 https://www.hhs.gov/sites/default/files/pfizer-inc-covid-19-vaccine-contract.pdf https://www.nejm.org/doi/full/10.1056/nejmoa2034577

Written by 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1632874124782477316

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1632905763583606786
  • noteId - 1632905763583606786
  • participantId - 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31
  • noteAuthorParticipantId -
  • createdAtMillis - 1678150046614
  • tweetId - 1632874124782477316
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Pfizer and BioNTech entered into an agreement for the co-development and distribution of a potential mRNA-based coronavirus vaccine aimed at preventing COVID-19 infection. Data from the clinical trial showed BNT162b2 was 95% effective in preventing Covid-19 https://www.hhs.gov/sites/default/files/pfizer-inc-covid-19-vaccine-contract.pdf https://www.nejm.org/doi/full/10.1056/nejmoa2034577

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-03-07 00:47:26 UTC
(1678150046614)		 1969-12-31 23:59:59 UTC
(-1)		 2023-03-07 02:11:29 UTC
(1678155089929)		 NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-03-06 23:24:59 -0600 08B58AAD2FFAA9F62791CED1BF7D3BB8691E797A55D9A1FCD56FD628270AFFF5 Rating Details
2023-03-06 19:38:35 -0600 157949CA27417AE3FA2F206BF999B2137E57038260C7F6E46A9CE23270241D9A Rating Details
2023-03-07 13:50:16 -0600 276C06F9D896C6B4A344124BD9E5809820306FACCDCC1682EEC9AE51EE4226BD Rating Details
2023-03-06 20:11:01 -0600 29C991F0507FE633C2F69371FB338CD99717F214088C5CD3C65ADA1931661D64 Rating Details
2023-03-06 22:13:36 -0600 3A631CF5FD50307F8E148F6FFA31D371FD630CCC10564B17E20B01B8C7C872F8 Rating Details
2023-03-06 23:09:38 -0600 45060ED935D102E05C21C743FE433C0B17B27D8FCF69CED01A2AD3F9AB2815B1 Rating Details
2023-03-10 05:06:02 -0600 4728CCFF1FDC2B9D519CBAB0DFDD86A3CBC85E80617B5EE2713527F4376B588C Rating Details
2023-03-07 00:58:55 -0600 4796F6AF7A2633A9B7FB4A3C898275B638C117C5DDD8069EB9B2328BED60AF40 Rating Details
2023-03-06 18:59:42 -0600 4C9C9C9232A2FFC3397EF49BC82CD9F579BE5769129385A4CF22FF562AB61777 Rating Details
2023-03-07 00:45:00 -0600 5942A49E1CC5D96F46CA100FD2785998770830291838C16067F200844BC090D4 Rating Details
2023-03-06 22:43:35 -0600 5D6BCF0E08FB9664D3D1B3CB6CA1EFA33EA65B6A1AD1AB3CC687354E190B83AC Rating Details
2023-03-06 19:56:09 -0600 623F900CD7C9F8C490EF084B063BCAA87DFECDFC5B94A127B70830D86D50EAF5 Rating Details
2023-03-06 18:55:48 -0600 6A06DF9ED1C50609064C3C37DA7578D835187AE231C609DB66B13A348371A3B5 Rating Details
2023-03-06 23:00:33 -0600 6A233F8462E21D5C21995653A56A767F726EE6520589B92C9FAA78AAE14A4943 Rating Details
2023-03-06 23:06:27 -0600 72B377667CE7FAC1106C7F93CD4827821915A97F3D9E186F11BF76BB5844BB3E Rating Details
2023-03-06 22:14:32 -0600 7E471D427B95B6B16C3D221D95EBA541CF8E77BE28701F8A347819D76A9D3C2A Rating Details
2023-03-07 00:18:33 -0600 8EEB74836816E3149B6EA4E6F39D736189B150426AF4DDD0CFCC0BFF0B081BBF Rating Details
2023-03-07 00:34:31 -0600 920E30AE9EE151DBC62326315A4F693A45E73E28E7D05CA74176ABF936F66FB2 Rating Details
2023-03-06 19:07:36 -0600 95DC647DE5438A4AA0FCCEC7C75EBC2932C1AA54DA3D99F4050226BDE2C8070F Rating Details
2023-03-07 07:00:51 -0600 97BA278ED28250BF11103CB9464DDB39E1949B2726B6989F32E5487DCB66586D Rating Details
2023-03-07 00:47:42 -0600 98C227EB9789B7F56DC293174ECCE68D1128450C4E485C5D3EF3AFE31BC7130B Rating Details
2023-03-06 19:10:00 -0600 9AD595B701167DE73F25FC67E8E758737FE297EB40C6B14DFA15EAE009148C91 Rating Details
2023-03-06 22:21:41 -0600 A60192297661B0E7F118E9800305D592896AFF42788364314F2936C4B3217E25 Rating Details
2023-03-07 11:27:26 -0600 AB465CA1F3AA15CE72433F9AE21516C2DEF53A5D11B2F2AB229037579530AFD5 Rating Details
2023-03-06 23:20:37 -0600 ADA7A6B861E84F16A9AC3EE64215DB07837986FF7A1CF25A4D643148B37B51E4 Rating Details
2023-03-07 10:26:14 -0600 C23ACBDBAE817E3156106806F85A7FCC9C798EE24871563B9987CCE76C381613 Rating Details
2023-03-06 21:36:44 -0600 C378931E048482D2BFDF00DC95644D6377CBCB812C79FF87D77B5E48595B3DA3 Rating Details
2023-03-06 20:04:12 -0600 C966E0BA5803EDA2B9ADEA1A226B5D5FB13629349A2D9A920F01C5137F8AF13B Rating Details
2023-03-06 23:06:21 -0600 CE565364586FCD845A17BF4193941F42ED0249E4594BA474ED39F2D1C14995D0 Rating Details
2023-03-06 19:33:28 -0600 D799A97194C7AB7F52822EA5D7A5D79521A4B56F3B7BCE89301300FCFB2001D2 Rating Details
2023-03-06 22:50:34 -0600 EDD572FD8B14EAD4FEBF4116E615BB1E8AC2FFFB3DD2E1D5309A15F55855AA41 Rating Details
2023-03-07 10:15:30 -0600 EE765F8250EF71F9C260367E74B1D2A11AD49042835E38E4DAD423C3B10FC755 Rating Details
2023-03-06 23:04:30 -0600 EE848598DCEB775E05753C8F9E2E1AE83D325CB4435FD8358DDAE49CFFA026ED Rating Details
2023-03-06 20:36:47 -0600 FBE99648971AA8D10A4E19F089EEC755A9CEC8D871D2362BA27780842697D836 Rating Details
2023-03-07 00:20:19 -0600 FF4D14ECB44DF49A1B7C50B81F8713E48DEA0FFAE6D09353483A100132988F62 Rating Details
2023-03-06 20:04:12 -0600 Rating Details
2023-03-06 23:20:37 -0600 Rating Details
2023-03-06 23:24:59 -0600 Rating Details
2023-03-07 00:18:33 -0600 Rating Details
2023-03-07 00:47:42 -0600 Rating Details
2023-03-07 11:27:26 -0600 Rating Details
2023-03-10 05:06:02 -0600 Rating Details
2023-03-07 13:50:16 -0600 Rating Details
2023-03-06 21:36:44 -0600 Rating Details
2023-03-06 23:09:38 -0600 Rating Details
2023-03-07 10:26:14 -0600 Rating Details
2023-03-06 23:00:33 -0600 Rating Details
2023-03-06 23:04:30 -0600 Rating Details
2023-03-07 00:45:00 -0600 Rating Details
2023-03-06 20:11:01 -0600 Rating Details
2023-03-06 19:38:35 -0600 Rating Details
2023-03-07 00:20:19 -0600 Rating Details
2023-03-06 19:33:28 -0600 Rating Details
2023-03-07 00:34:31 -0600 Rating Details
2023-03-06 22:13:36 -0600 Rating Details
2023-03-07 00:58:55 -0600 Rating Details
2023-03-07 10:15:30 -0600 Rating Details
2023-03-06 18:59:42 -0600 Rating Details
2023-03-06 19:56:09 -0600 Rating Details
2023-03-06 19:10:00 -0600 Rating Details
2023-03-06 22:14:32 -0600 Rating Details
2023-03-06 22:43:35 -0600 Rating Details
2023-03-07 07:00:51 -0600 Rating Details
2023-03-06 22:21:41 -0600 Rating Details
2023-03-06 19:07:36 -0600 Rating Details
2023-03-06 23:06:21 -0600 Rating Details
2023-03-06 20:36:47 -0600 Rating Details
2023-03-06 18:55:48 -0600 Rating Details
2023-03-06 23:06:27 -0600 Rating Details
2023-03-06 22:50:34 -0600 Rating Details